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Careful clinical judgment is important 
in decision for neuroimaging
Determining the utility of neuroimaging for
headache is a taxing question for clinicians 
working in the emergency room or an outpatient
clinic. In the county health system where I work, 
I find it increasingly difficult to get neuroimaging
studies done within an appropriate time frame.
Thus I must rely heavily on clinical judgment to
determine how urgently they must be done. I also
feel an ethical obligation to avoid unnecessary
demands on this limited resource. 
I have found the criteria recommended in this
Clinical Inquiry to be most helpful in prioritizing
the need for neuroimaging. These include focal
neurological deficit, alteration in the character 
of headache, persistence of headache despite 
analgesics, abrupt onset, and increasing 
frequency and intensity of headache. In addition, 
I have found the persistence of the patient in
returning for reevaluation to be a helpful 
indicator of pathology.  
Zahida Siddiqi, MD
Baylor College of Medicine, Houston, Tex
Neuroimaging is warranted to evaluate headaches
when patients present to an emergency department
with signs or symptoms of an intracranial lesion.
These signs or symptoms include abrupt onset 
of headache, focal neurological abnormalities
(strength of recommendation [SOR]: B, based 
on a validating cohort study), decreased level of
consciousness (SOR: B, based on a retrospective,
nonconsecutive case study), occipitonuchal 
location, multiple associated symptoms, and age
older than 55 years (SOR: B, based on a case-
control study). 
Neuroimaging is also recommended in the 
ambulatory setting for patients with headaches of
migraine type and abnormal findings on neurological
exam; that are accompanied by signs or symptoms
of increased intracranial pressure; or that are new
for a patient who is HIV-positive (SOR: C, based on
expert opinion).
There are no studies or consistent opinions 
on the need for neuroimaging with headaches 
of tension type, described as the “worst ever,” 
increasing in frequency, that awaken the patient, or
are associated with nausea, dizziness, or syncope.
C L I N I C A L C O M M E N T A R Y
■ Evidence summary
A validating cohort study looked at 5 clin-
ical warning criteria (TABLE) for patients
seen in an emergency department for
headache; 70 adults with acute headache
as the chief complaint were included. All
patients received computed tomography
(CT) scanning as part of their evaluation.
Abrupt onset and focal neurologic findings
most strongly predicted intracranial
lesions. Overall, 36% of the patients
(25/70) had significant pathology.1
A retrospective study reviewed records
of 111 patients seen in an emergency
department with headache and who had
undergone neuroimaging (CT or magnetic
resonance imaging [MRI]). Three symp-
toms predicted a lesion: decreased level of
consciousness (sensitivity=23%; positive
likelihood ratio [LR+] =3.8), paralysis (sen-
sitivity=25%; LR+ =3.5), and papilledema
(numbers not reported). In this study, 35%
(39/111) of those receiving neuroimaging
had intracranial pathology.2
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A case-control study reviewed hospital
records of 468 patients evaluated in the
emergency department for nontraumatic
headache. Neuroimaging (CT scan or cere-
bral angiogram) was performed for 160 of
these patients. Final diagnosis and outcome
was obtained at 6 months. The symptoms
and their ability to predict intracranial
pathology are as follows: abnormal neuro-
logic examination (sensitivity=39%; LR+
=19.5), location of headache (sensitivi-
ty=78%; LR+ =4.87), age of patient (sensi-
tivity=61%; LR+ =2.26), multiple associat-
ed symptoms (sensitivity=61%; LR+
=2.26), mode of onset of headache (sensitiv-
ity=78%; LR+ =2.23), and presence of asso-
ciated symptoms (sensitivity=89%; LR+
=1.41). Again, abnormal neurologic exami-
nation was the most significant indicator for
imaging. This study did not define associat-
ed symptoms nor did it specify what deter-
mined which patients were imaged.3
Information concerning the workup of
headache in the ambulatory setting is limit-
ed. In actual practice, only about 3% of
patients who present with a new headache
in the office setting have neuroimaging
ordered.4 When neuroimaging is performed,
about 4% of CT scans find a significant and
treatable lesion (in one sample of 293 CT
scans, there were 12 true-positive scans and
2 false-positive scans).5 Expert guidelines
regarding headaches among ambulatory
patients recommend neuroimaging for
migraine patients only in the presence of per-
sistent focal abnormal neurological findings.
They note insufficient evidence for recom-
mendations concerning neuroimaging for
patients with tension-type headaches. They
also note insufficient evidence for or against
neuroimaging when headache occurs in the
presence or absence of nonfocal symptoms:
dizziness, syncope, nausea, lack of coordina-
tion, the “worst headache ever,” headache
that awakens the patient from sleep, and
increasing frequency of headaches.6
Recommendations from others
Rosen’s Emergency Medicine and Mettler:
Essentials of Radiology add the following
indications for imaging in headache: signs
and symptoms of elevated intracranial
pressure (eg, papilledema); meningismus;
partial seizure; nocturnal headaches that
awaken the patient from sleep; increase in
pain with coughing, sneezing or change in
body position; sudden onset headaches
that reach maximum intensity in 2 to 3
minutes; headache associated with mental
status changes or decreased alertness; any
new headache in an HIV-positive patient.7,8 
R E F E R E N C E S
1. Aygun D, Bildik F. Clinical warning criteria in evaluation
by computed tomography the secondary neurological
headaches in adults. Eur J Neurol 2003; 10:437–442.
2. Sobri M, Lamont AC, Alias NA, Win MN. Red flags in
patients presenting with headache: clinical indications
for neuroimaging. Br J Radiol 2003; 76:532–535.
3. Ramirez-Lassepas M, Espinosa C, Cicero JJ, Johnston
KL, Cipolle RJ, Barber DL. Predictors of intracranial
pathologic findings in patients who see emergency care
because of headache. Arch Neurol 1997; 54:1506–1509.
4. Becker L, Iverson DC, Reed FM, Calonge N, Miller RS,
Freeman WL.  Patients with a new headache in primary
care: a report from ASPN. J Fam Pract 1988; 27:41–47.
5. Becker LA, Green LA, Beaufait D, Kirk J, Froom J,
Freeman WL. Use of CT scans for the investigation of
headache: a report from ASPN, part 1. J Fam Pract
1993; 37:129–134.
6. Morey SS. Headache Consortium releases guidelines
for use of CT or MRI in migraine work-up. Am Fam
Physician 2000; 62:1699–1701.
7. Mettler FA Jr. Essentials of Radiology. 2nd ed.
Philadelphia, Pa: Saunders; 2005.
8. Marx JA, Hockberger RS, Walls JM. Rosen’s
Emergency Medicine: Concepts and Clinical Practice.
5th ed. St. Louis, Mo: Mosby; 2002.
T A B L E
SENSITIVITY SPECIFICITY 
CLINICAL FEATURE FOR INTRACRANICAL PATHOLOGY LR+ LR–
Presence of focal  1.0 0.76 4.21 0
neurological  
symptoms or findings
Abrupt onset 0.55 0.79 2.5 0.57
Alteration of 0.67 0.67 2.0 0.49
characteristics
Increased intensity 0.39 0.73 1.44 0.83
and frequency
Persistence despite 0.60 0.56 1.36 0.71
analgesics
LR+, positive likelihood ratio; LR–, negative likelihood ratio. 
Source: Aygun and Bildik, Eur J Neurol 2003.1
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Abrupt onset and
focal neurologic
findings most
strongly predict
intracranial
lesions
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